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Abstract
Behçet disease (BD) is a chronic, relapsing, multisystemic vasculitis with unknown etio-
pathogenesis. It is widely accepted that an altered immune response triggered by an 
infectious agent or by an otoantigen in a genetically predisposed individual plays major 
role in the pathogenesis of BD. In this chapter, the role of infectious agents in the etio-
pathogenesis of BD was discussed.
Keywords: Behcet’s disease, etiopathogenesis, infectious agent, streptococci, gut 
microbiota
1. Introduction
Behçet’s disease (BD) is a chronic, recurrent, inflammatory, multisystemic disease character-
ized by oral and genital ulcerations, uveitis, and skin lesions. Although the etiopathogenesis of 
BD is still unknown, it is thought that the altered immune response against some environmen-
tal triggering factors in genetically susceptible individuals plays a major role in pathogenesis. 
It is widely accepted that endothelial injury, neutrophils, and the tendency to thrombosis also 
contribute to the pathogenesis of BD [1, 2]. The presence of familial cases, unusual geographi-
cal distribution of the disease, and the strong association of BD with the major histocompat-
ibility complex (MHC), suggests that genetic factors may play a role in etiopathogenesis [1]. 
But, genetic factors alone are not sufficient to elucidate the etiology of BD. Today, it is believed 
that the disease process is triggered by an unknown infectious or environmental agent in a 
genetically predisposed individual [3]. The studies showing a decrease in the risk for devel-
opment of BD in people who migrate from the regions with higher prevalence for BD to the 
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regions with lower prevalence support the role of environmental factors in etiology [4]. In this 
chapter, possible infectious triggering factors will be discussed.
Among the environmental factors, the role of infectious agents such as bacteria (Streptococcus, 
Helicobacter pylori, Mycoplasma fermentans, Mycobacteria and Borrelia burgdorferi) and viruses 
(Herpes simplex virus (HSV) type 1 and 2, hepatitis viruses, Cytomegalovirus, Varicella zoster virüs 
(VZV), Epstein-Barr virüs (EBV) and Parvovirus B19) is mostly emphasized [3, 5].
A decreased positive pathergy frequency after surgical cleaning of skin before pathergy test-
ing, the reduction of the frequency and duration of mucocutaneous findings of BD with pro-
phylactic penicillin treatment, and the greater frequency of chronic tonsillitis and tooth decay 
in these patients are important findings that suggest the role of microorganisms in BD [1, 5, 6].
Oropharyngeal pathogens are the most blamed agents in pathogenesis, as almost all indi-
viduals with BD have oral aphthae [7]. After dental procedures, increased frequency of oral 
ulcers and activation of disease support this view [5, 8]. It has been suggested that this condi-
tion occurs as a consequence of the passage of microorganismal antigens from oral cavity into 
the bloodstream [5].
2. Bacteria
Because of predominancy of streptococci in oral cavity and dental infections, they are the 
most frequently investigated bacteria in BD. In patients with BD, it has been shown that oral 
hygiene is impaired and periodontal scores are high associated with disease severity [9, 10]. 
The proportion of Streptococcus sanguinis in oral flora has been found to be higher in indi-
viduals with BD than in healthy individuals [3]. Antibodies against S. sanguinis and S. pyo-
genes have been detected more frequently in the sera of BD patients than in the control group 
[5, 8]. In one study, oral ulceration had occurred after application of streptococcal antigens 
to the oral mucosa by prick test [5]. It has been suggested that streptococci penetrate to the 
oral mucosa with their enzymes such as IgA 1 protease and neuraminidase and lead to the 
development of hypersensitivity against streptococci in BD individuals [5]. There are studies 
suggesting that, in addition to S. sanguinis there may be an association between S. pyogenes, 
Streptococcus faecalis, Streptococcus viridans, Streptococcus haemolyticus, and Streptococcus sali-
varius with BD [5, 8].
In addition to streptococcal antigens, it was shown that a common non-peptide antigen pres-
ent in many bacteria, such as Escherichia coli, Staphylococcus aureus, can also activate γδ-T cells 
in BD. This finding suggests that T lymphocytes of BD patients are hyperactive to bacterial 
antigens in general, not against a specific bacteria [3, 7, 11]. In one study, it was shown that 
T cells in BD patients are stimulated with staphylococcal enterotoxins even at low concentra-
tions that could be achieved under physiological conditions and stimulate IFN-γ production 
much more than the control group. The increased sensitivity of patients T cells to the several 
bacterial antigens may explain the exacerbation of systemic symptoms of BD after infections, 
dental caries treatments, operations, or trauma [11].
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H. pylori is another bacteria that have been investigated in relation to BD [12–14]. In some stud-
ies, the prevalence of H. pylori was found to be high in patients with BD, and it was suggested 
that there was a relationship between the presence of H. pylori and gastrointestinal involvement 
[12, 14]. Although improvement in symptoms of BD after H. pylori eradication treatment have 
been reported in some uncontrolled studies, there are studies that do not support this [5, 14].
There are reports that some other bacteria, such as M. fermentans, Mycobacteria, Prevotella, 
Fusobacterium and B. burgdorferi, also induce BD, but there is no strong correlation with them [3, 5].
3. Viruses
The possible etiological relationship between viral infections and BD has been first suggested 
by Hulusi Behçet, due to the observation of intracellular inclusion bodies in specimens taken 
from aphthous lesions and was investigated by many researchers [6]. The HSV-1 genome was 
detected in oral and genital ulcers of BD patients [3, 6]. The amount of HSV-1 DNA in leuko-
cytes, blood and saliva samples, and the anti-HSV-1 antibodies in serum samples of BD patients 
were found to be significantly higher than control group [5, 6]. The presence of immunocom-
plexes containing HSV-1 antigen in the blood has also been reported [15]. Besides these studies 
supporting the role of HSV in etiology, the results of several other studies in which HSV DNA 
could not be demonstrated in leukocytes, oral, and genital ulcers of BD and, improvement in 
clinical symptoms could not be obtained with antiviral therapy against HSV virus, have lead 
to giving up the hypothesis that HSV plays a role in the development of BD [3, 5]. However, in 
the light of today’s information, it is thought that the immune response to HSV infection rather 
than active infection with HSV may play a role in the pathogenesis of the disease [5].
Since hepatitis viruses play a role in many vasculitic diseases, their role in the etiology of BH 
has been investigated. Although, in one study, Hepatitis B virus was detected more frequently 
in patients with BD, Hepatitis A, B, C, E and G viruses have not been shown to be associated 
with BD [5].
Parvovirus B19, considered to be the causative agent in the development of numerous vascu-
litic diseases, has been detected more frequently in non-ulcerous lesions of BD, such as ery-
thema nodosum, papulopustular reactions, than genital and extragenital ulcers and control 
skin biopsies but these results are not enough to prove the role of parvoviruses in BD [5, 16].
In addition to these viruses, it has been suggested that there may also be a relationship 
between human immunodeficiency virus, VZV, Cytomegalovirus, EBV and BD, but this relation-
ship has not been proved [5].
Although many infectious agents have been suggested in the etiopathogenesis of BD, there is 
no definitely proven or isolated microorganism that plays a role in etiology. For this reason, it 
is now widely accepted that BD does not originate directly from infectious agents, but micro-
organisms alter immune response leading to autoimmune and inflammatory diseases. So, the 
studies have shifted on the role of the heat shock proteins (HSP), the cytokine profile changes 
and, the T cell hypersensitivity.
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4. Heat shock proteins
The more accepted view about the role of microorganisms in the etiology of BD is that the 
microorganisms mentioned in the etiology carry some antigens (HSP, etc.) which are simi-
lar to the human proteins and the resulting cross-reaction is the cause of the immunological 
response [4, 15, 17]. HSP is a group of proteins that are synthesized by all eukaryotic and 
prokaryotic cells, as a result of physiological shock (heat, anoxia, trauma, etc.) and microbial 
stimulus, and are expressed on the cell membrane [1, 3]. These proteins protect the cells from 
severe damage and premature death (apoptosis) [3]. Bacterial 65-kDa HSP (HSP65), which 
was isolated from mycobacterium at first, exhibits a largely similar amino acid sequence with 
human mitochondrial 60-kDa HSP (HSP60), and it is thought that the cross-reaction between 
them result in immune response [4, 17]. It is postulated that human HSP60-specific auto-
reactive T cell clones are formed as a result of this cross-reaction and immunopathological 
changes of BD occur [8]. HSP60 can lead to production of proinflammatory cytokines (IL6, 
IL12, IL15, and TNF-a), expression of cell adhesion molecules (ICAM and VCAM) and Th1 
immune response by binding to Toll-like receptors 2 and 4 [3].
5. Molecular similarity
Retinal S antigen present in the retina shows homology with HLA-B51 and HLA-B27. 
Immune-mediated response to retinal S antigen develops only due to retinal damage after 
uveitis [4]. These data suggest that Retinal S antigen may play a role in the pathogenesis of 
BD through molecular similarity [3].
Bes-1, a S. sanguinis gene, was found in the monocytes in mucocutaneous lesions of BD. The 
more than 60% similarity of the amino acid sequence of the Bes-1 gene with the human intra-
ocular ganglion peptide, Brn-3b, suggests that the uveitis in BD may occur due to molecular 
similarity between the microbial and host antigens [18].
6. Antimicrobial peptides
Another research topic related to environmental factors is antimicrobial peptides. Çiçek et al. 
found serum and saliva concentration of hepcidin, an antimicrobial peptide, in patients with 
BD and recurrent aphthous stomatitis are lower than in the control group and concluded that 
low hepcidin levels may be associated with oral aphthous lesion development [19].
7. Mannose-binding lectins
Mannose-binding lectins (MBL), part of natural immunity, bind to mannose and N-acetylglu-
cosaminomines on the surface of many microorganisms and lead killing of them by  complement 
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activation [5]. It is thought that the low level of mannose-binding lectin detected in BD cor-
relates with disease activity and is associated with the colonization of S. aureus in pustular 
lesions [20].
8. Gut microbiota
Recent data indicate that gut microbiota plays an important role in human health. The 
dysbiosis of gut microbiota has been implicated in the etiopathogenesis of many diseases. 
In a recent study, comparing gut microbiota of patients with BD and healthy controls, the 
genera Roseburia and Subdoligranulum were found to be significantly depleted in patients 
with BD. Also, the butyrate production was found to be significantly decreased in these 
patients [21].
9. Conclusion
The etiopathogenesis of BD is still unclear. Although many infectious agents have been pro-
posed in the etiopathogenesis, there is no definitely proven or isolated microorganism that 
plays a role in etiology. Today, it is believed that the altered immune response against an 
unknown infectious triggering agent in genetically susceptible individuals may play a role in 
the pathogenesis of BD.
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